CompanyDeals

Wecare Medical Secures Pre-Series A Funding to Advance Brain Health Technology

CompanyDeals

Sandoz Inks Deal with Samsung Bioepis for Ustekinumab Biosimilar SB17

Policy / Regulatory

China Updates Narcotics and Psychotropic Substances Catalog, Adds Three Substances

CompanyDrug

Sinovac Biotech Advances SA55 COVID-19 Neutralizing Antibody into Phase II Trials

CompanyDeals

Shanghai Haoyuan Chemexpress Aims to Raise RMB 1.16 Billion with Convertible Bonds

CompanyDrug

Jiangsu Hengrui Pharmaceuticals Gets NMPA Approval for HRS-7450 Acute Ischemic Stroke Study

CompanyDrug

SinoMab BioScience Receives NMPA Approval for Phase I Study of Atopic Dermatitis Drug SM17

Company

Merck & Co. Becomes First Multinational to Register Unit in Hainan’s Lecheng Pilot Zone

CompanyDrug

Haisco Pharmaceutical Gets NMPA Approval for HSK21542 Chronic Pruritus Clinical Study

CompanyDrug

ImmuneOnco’s IMM2510 and IMM27M Achieve Milestones in Phase I Clinical Trials

CompanyDrug

CDE Indicates BTD Status for Visirna’s VSA001, Sperogenix’s Vamorolone, and Zai Lab’s Efgartigimod

CompanyDeals

Shanghai Junshi Biosciences to Acquire Stake in Anlingke Biopharmaceutical for Cancer Therapy Programs